DK0817626T3 - Anvendelse af fumagillol og derivater deraf til fremstilling af lægemidler mod tarminfektioner - Google Patents

Anvendelse af fumagillol og derivater deraf til fremstilling af lægemidler mod tarminfektioner

Info

Publication number
DK0817626T3
DK0817626T3 DK96909200T DK96909200T DK0817626T3 DK 0817626 T3 DK0817626 T3 DK 0817626T3 DK 96909200 T DK96909200 T DK 96909200T DK 96909200 T DK96909200 T DK 96909200T DK 0817626 T3 DK0817626 T3 DK 0817626T3
Authority
DK
Denmark
Prior art keywords
fumagillol
drugs
derivatives
manufacture
intestinal infections
Prior art date
Application number
DK96909200T
Other languages
Danish (da)
English (en)
Inventor
Jean-Michel Molina
Francis Derouin
Original Assignee
Assist Publ Hopitaux De Paris
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assist Publ Hopitaux De Paris, Sanofi Synthelabo filed Critical Assist Publ Hopitaux De Paris
Application granted granted Critical
Publication of DK0817626T3 publication Critical patent/DK0817626T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Epoxy Compounds (AREA)
DK96909200T 1995-03-27 1996-03-26 Anvendelse af fumagillol og derivater deraf til fremstilling af lægemidler mod tarminfektioner DK0817626T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9503549 1995-03-27
PCT/FR1996/000448 WO1996030010A2 (fr) 1995-03-27 1996-03-26 Utilisation du fumagillol et ses derives pour preparer les medicaments destines a combattre les infections intestinales

Publications (1)

Publication Number Publication Date
DK0817626T3 true DK0817626T3 (da) 1999-07-12

Family

ID=9477436

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96909200T DK0817626T3 (da) 1995-03-27 1996-03-26 Anvendelse af fumagillol og derivater deraf til fremstilling af lægemidler mod tarminfektioner

Country Status (25)

Country Link
US (1) US5900431A (cs)
EP (1) EP0817626B1 (cs)
JP (1) JP3260378B2 (cs)
KR (1) KR100286920B1 (cs)
CN (1) CN1072485C (cs)
AP (1) AP646A (cs)
AT (1) ATE172641T1 (cs)
AU (1) AU706161B2 (cs)
CA (1) CA2216623C (cs)
CZ (1) CZ286821B6 (cs)
DE (1) DE69600879T2 (cs)
DK (1) DK0817626T3 (cs)
EA (1) EA000150B1 (cs)
ES (1) ES2128846T3 (cs)
FR (1) FR06C0014I2 (cs)
HU (1) HU224028B1 (cs)
IS (1) IS2048B (cs)
NO (1) NO315968B1 (cs)
NZ (1) NZ304906A (cs)
OA (1) OA10515A (cs)
PL (1) PL183378B1 (cs)
SK (1) SK283883B6 (cs)
TR (1) TR199701048T1 (cs)
UA (1) UA41446C2 (cs)
WO (1) WO1996030010A2 (cs)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69600879T2 (de) * 1995-03-27 1999-06-02 Assistance Publique, Hopitaux De Paris, Paris Verwendung von fumagillol und seinen derivaten zur herstellung von arzneimitteln gegen darminfektionen
EP0799616A1 (en) * 1996-04-01 1997-10-08 Takeda Chemical Industries, Ltd. Oral composition comprising a fumagillol derivative
AU2811400A (en) * 1999-02-26 2000-09-14 Sanofi-Synthelabo Stable formulation containing fumagillin
JP3265394B1 (ja) * 2001-03-14 2002-03-11 泰三 矢野 アクリル系樹脂手袋
DE10341887A1 (de) * 2003-09-09 2005-03-31 Leopold Kostal Gmbh & Co. Kg Elektrisches Schaltermodul
FR2886855B1 (fr) * 2005-06-08 2009-07-17 Agronomique Inst Nat Rech Utilisation de la fumagilline et de ses derives pour augmenter la biodisponibilite des lactones macrocyliques
US8399512B2 (en) * 2007-11-28 2013-03-19 Mersana Therapeutics, Inc. Biocompatible biodegradable fumagillin analog conjugates
CN102123586A (zh) * 2008-07-18 2011-07-13 法弗根股份有限公司 治疗超重或肥胖受试者的方法
US20120004162A1 (en) 2008-12-04 2012-01-05 Vath James E Methods of Treating an Overweight or Obese Subject
US8642650B2 (en) 2008-12-04 2014-02-04 Zafgen, Inc. Methods of treating an overweight or obese subject
WO2013055385A2 (en) 2011-10-03 2013-04-18 Zafgen Corporation Methods of treating age related disorders
CA2777108A1 (en) 2009-10-09 2011-04-14 Zafgen Corporation Sulphone compounds and methods of making and using same
WO2011085198A1 (en) 2010-01-08 2011-07-14 Zafgen Corporation Metap-2 inhibitor for use in treating benign prostatic hypertrophy (bph)
JP5827239B2 (ja) 2010-01-08 2015-12-02 ザフゲン,インコーポレイテッド フマギロール型化合物並びにその製造方法及び使用方法
WO2011127304A2 (en) 2010-04-07 2011-10-13 Zafgen Corporation Methods of treating an overweight subject
BR112013001613A2 (pt) 2010-07-22 2016-05-24 Zafgen Inc compostos tricíclicos e métodos para fazer e usar os mesmos.
UA111479C2 (uk) 2010-11-09 2016-05-10 Зафджен, Інк. Кристалічні форми інгібітору metap-2 та способи їх отримання і застосування
WO2012075020A1 (en) 2010-11-29 2012-06-07 Zafgen Corporation Treatment of obesity using non-daily administration of 6 - 0 - (4 - dimethylaminoethoxy) cinnamoyl fumagillol
JP6058557B2 (ja) 2011-01-26 2017-01-11 ザフゲン,インコーポレイテッド テトラゾール化合物ならびにその作製方法および使用方法
WO2012122264A1 (en) 2011-03-08 2012-09-13 Zafgen Corporation Oxaspiro [2.5] octane derivatives and analogs
AU2012253760B2 (en) 2011-05-06 2016-02-04 Zafgen, Inc. Tricyclic pyrazole sulfonamide compounds and methods of making and using same
KR20140053013A (ko) 2011-05-06 2014-05-07 자프겐 인크. 삼환식 설폰아마이드 화합물 그리고 그의 제조방법 및 그를 이용하는 방법
EA025526B1 (ru) 2011-05-06 2017-01-30 Зафджен Инк. Частично насыщенные трициклические соединения и способы их получения и применения
AU2013209723B2 (en) 2012-01-18 2016-11-24 Zafgen, Inc. Tricyclic sulfonamide compounds and methods of making and using same
CA2861381A1 (en) 2012-01-18 2013-07-25 Zafgen, Inc. Tricyclic sulfone compounds and methods of making and using same
MX2014013525A (es) 2012-05-07 2015-10-22 Zafgen Inc Sal polimorfica de la sal de oxalato de 6-o-(4-dimetilaminoetoxi)c inamoil fumagilol y metodos para elaborarla y utilizarla.
WO2013169857A1 (en) 2012-05-08 2013-11-14 Zafgen, Inc. Treating hypothalamic obesity with metap2 inhibitors
WO2013169860A1 (en) 2012-05-09 2013-11-14 Zafgen, Inc. Fumigillol type compounds and methods of making and using same
BR112015010225A2 (pt) 2012-11-05 2017-07-11 Zafgen Inc compostos tricíclicos e seus métodos de produção e utilização
CN104918615B (zh) 2012-11-05 2018-10-12 扎夫根股份有限公司 治疗肝病的方法
EP2925737B1 (en) 2012-11-05 2017-06-14 Zafgen, Inc. Tricyclic compounds for use in the treatment and/or control of obesity
AU2014236528A1 (en) 2013-03-14 2015-09-24 Zafgen, Inc. Methods of treating renal disease and other disorders
AR105671A1 (es) 2015-08-11 2017-10-25 Zafgen Inc Compuestos heterocíclicos de fumagillol y sus métodos de elaboración y uso
CN106432255A (zh) 2015-08-11 2017-02-22 扎夫根公司 烟曲霉素醇螺环化合物和制备和使用其的方法
CN106591389B (zh) * 2015-10-15 2019-10-11 中国科学院微生物研究所 一种利用烟曲霉菌生产烟曲霉素的方法
CN105622593B (zh) * 2016-02-25 2018-06-26 中国农业科学院蜜蜂研究所 一种烟曲霉素的提取方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2791530A (en) * 1953-08-31 1957-05-07 Abbott Lab Stabilized fumagillin compositions
JPH0629278B2 (ja) * 1985-06-26 1994-04-20 藤沢薬品工業株式会社 オキサスピロオクタン化合物
US5135920A (en) * 1988-11-16 1992-08-04 Takeda Chemical Industries, Ltd. Angiostatic agents
EP0541716A1 (en) * 1990-07-27 1993-05-19 Repligen Corporation Novel methods and compositions for treatment of angiogenic diseases
US5328930A (en) * 1993-03-01 1994-07-12 Emory University Treatment of microsporidial and acanthamoeba keratoconjunctivitis with topical fumagillin
DE69600879T2 (de) * 1995-03-27 1999-06-02 Assistance Publique, Hopitaux De Paris, Paris Verwendung von fumagillol und seinen derivaten zur herstellung von arzneimitteln gegen darminfektionen
EP0799616A1 (en) * 1996-04-01 1997-10-08 Takeda Chemical Industries, Ltd. Oral composition comprising a fumagillol derivative
CA2210600A1 (en) * 1996-07-17 1998-01-17 Takashi Houkan Inhibitor of tumor metastasis or recurrence
AU3968597A (en) * 1996-08-02 1998-02-25 Children's Medical Center Corporation Method of regulating the female reproductive system through angiogenesis inhibitors

Also Published As

Publication number Publication date
CA2216623C (en) 2005-05-31
KR19980703271A (ko) 1998-10-15
JP3260378B2 (ja) 2002-02-25
CA2216623A1 (en) 1996-10-03
HUP9801220A2 (hu) 1999-09-28
PL183378B1 (pl) 2002-06-28
FR06C0014I1 (cs) 2006-11-17
MX9707150A (es) 1998-07-31
NZ304906A (en) 1999-06-29
IS4557A (is) 1997-09-11
ATE172641T1 (de) 1998-11-15
ES2128846T3 (es) 1999-05-16
FR06C0014I2 (cs) 2006-12-29
IS2048B (is) 2005-09-15
HU224028B1 (hu) 2005-05-30
AP9701092A0 (en) 1997-10-31
EP0817626B1 (fr) 1998-10-28
AU706161B2 (en) 1999-06-10
CZ286821B6 (en) 2000-07-12
UA41446C2 (uk) 2001-09-17
SK130797A3 (en) 1998-03-04
HUP9801220A3 (en) 2001-10-29
DE69600879D1 (de) 1998-12-03
US5900431A (en) 1999-05-04
CN1179715A (zh) 1998-04-22
CZ304997A3 (en) 1997-12-17
WO1996030010A3 (fr) 1996-11-28
PL322470A1 (en) 1998-02-02
EP0817626A2 (fr) 1998-01-14
DE69600879T2 (de) 1999-06-02
NO974466D0 (no) 1997-09-26
CN1072485C (zh) 2001-10-10
AP646A (en) 1998-04-27
NO974466L (no) 1997-09-26
OA10515A (fr) 2002-04-24
KR100286920B1 (ko) 2001-04-16
SK283883B6 (sk) 2004-04-06
WO1996030010A2 (fr) 1996-10-03
TR199701048T1 (xx) 1998-01-21
NO315968B1 (no) 2003-11-24
AU5278696A (en) 1996-10-16
EA199700267A1 (ru) 1998-04-30
EA000150B1 (ru) 1998-10-29
JPH11506421A (ja) 1999-06-08

Similar Documents

Publication Publication Date Title
DK0817626T3 (da) Anvendelse af fumagillol og derivater deraf til fremstilling af lægemidler mod tarminfektioner
DK1167364T3 (da) Benzopyranholdige forbindelser og promedikamentformer af disse
NO305833B1 (no) Naftylforbindelser, mellomprodukter og anvendelse av forbindelsene
DK0876392T3 (da) Lacton-derivater af 17.beta.-carboxy, carbothio og amidandrostanforbindelser
NO20021172L (no) Farmasöytisk sammensetning
NO971422L (no) Medikamenter
DE69224656D1 (de) Arzneimittel
NO20011157L (no) Benzenderivater og farmasöytisk anvendelse derav
ATE223707T1 (de) Mehrphasige weichgelatine darreichungsform
BR9610214A (pt) Compostos farmacéuticos
NO962231L (no) Prolegemidler av paclitaxelderivater
FI931234A0 (fi) Foerfarande foer oevervakning av en patients tillstaond
NO983678D0 (no) Nye cefemforbindelser og farmasöytiske anvendelser derav
DE69529848D1 (de) Elektronisches medizinalthermometer
NO992724D0 (no) Farmas°ytiske blandinger inneholdende N-sulfonyl-indolin-derivater
FI955605A0 (fi) Aryloivia lääkkeitä
FI973280A0 (fi) Farmaseuttinen koostumus
PT850048E (pt) Granulos farmaceuticos
MX9204370A (es) Derivados de pirazol.
BR9607046A (pt) Derivados de 3-pirrolidiliden-2-ona-cefalosporinas
NO980471L (no) Benzensulfonamidderivater, fremstilling derav og terapautiske anvendelser derav
BR9609723A (pt) Derivados da tricetona
DK0869952T3 (da) Derivater af 5-naphthalen-1-yl-1,3-dioxaner, fremstilling og terapeutisk anvendelse heraf
NO965448D0 (no) Farmasöytiske forbindelser
BR9605777A (pt) Composição farmacêutica